UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Invesco LLC

Invesco LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 73.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,472 shares of the healthcare conglomerate’s stock after purchasing an additional 1,475 shares during the period. Invesco LLC’s holdings in UnitedHealth Group were worth $1,819,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Geode Capital Management LLC boosted its stake in shares of UnitedHealth Group by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock worth $10,068,869,000 after acquiring an additional 319,515 shares during the last quarter. Capital International Investors grew its holdings in shares of UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after buying an additional 906,365 shares in the last quarter. Norges Bank acquired a new position in UnitedHealth Group during the fourth quarter worth about $6,375,744,000. Northern Trust Corp raised its holdings in UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock valued at $4,807,527,000 after acquiring an additional 1,058,488 shares during the last quarter. Finally, Franklin Resources Inc. grew its position in shares of UnitedHealth Group by 10.7% in the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock valued at $4,514,178,000 after purchasing an additional 861,854 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil acquired 3,700 shares of the firm’s stock in a transaction that occurred on Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director now directly owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director John H. Noseworthy purchased 300 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The stock was acquired at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the acquisition, the director now directly owns 6,063 shares of the company’s stock, valued at approximately $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on UNH. KeyCorp cut their target price on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a research note on Monday, June 2nd. Baird R W downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, June 11th. Royal Bank Of Canada cut their price target on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Bank of America lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. Finally, TD Securities reaffirmed a “hold” rating and issued a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $427.09.

UnitedHealth Group Price Performance

UNH stock opened at $300.85 on Tuesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The business has a 50 day moving average price of $353.44 and a 200 day moving average price of $460.22. The stock has a market cap of $272.91 billion, a price-to-earnings ratio of 12.60, a PEG ratio of 1.42 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the prior year, the business earned $6.91 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be issued a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.94%. UnitedHealth Group’s payout ratio is presently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.